(Q42718752)

English

Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis

scientific article published on 17 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis (English)

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

1 reference

based on heuristic

inferred from title

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Binna Liu

1

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Kai Liu

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Yu Lu

3

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Dongfeng Zhang

4

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Tianming Yang

5

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Xuan Li

6

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Chen Ma

7

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Meiqin Zheng

8

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Bin Wang

9

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Gang Zhang

10

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Fei Wang

11

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Zhenkun Ma

12

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Chun Li

13

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Haihong Huang

14

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

Dali Yin

15

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

language of work or name

0 references

publication date

17 April 2012

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

17

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

4

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

4545-4559

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

copyright license

Creative Commons Attribution 4.0 International

17 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Current medical treatment for tuberculosis

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17044545

21 January 2018

Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17044545

21 January 2018

Antimycobacterial activities of riminophenazines

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17044545

21 January 2018

The pharmacology, metabolism, and chemistry of clofazimine.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17044545

21 January 2018

Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17044545

21 January 2018

Antituberculosis activities of clofazimine and its new analogs B4154 and B4157

1 reference

https://pubmed.ncbi.nlm.nih.gov/22510605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, distribution and retention of the riminocompounds in the experimental animal

1 reference

https://pubmed.ncbi.nlm.nih.gov/22510605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE ANTIMYCOBACTERIAL ACTIVITY OF B 663.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22510605

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/MOLECULES17044545

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6269036

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42718752&oldid=1967117190"